Highlights

  • Terragen Holdings shares rose 7.14% to AUD 0.015 on 16 November, with 19,000 shares traded during the session.
  • Terragen’s agricultural biotechnology portfolio includes a ruminant probiotic for beef and dairy cattle, calves and sheep across different farming operations.
  • The company makes Great Land Plus for cropping, pasture and horticulture, extending its range beyond products for livestock applications.
  • Terragen controls its master microbial seed stock and develops formulations through research, fermentation and Manufacturing before taking products to market.

Trading on 16 November 2026 lifted Terragen Holdings Limited (ASX:TGH) 7.14% to a closing price of AUD 0.015. The stock traded at a reported high and low of AUD 0.015 on Volume of 19,000 shares. Terragen’s Business spans livestock and crop products. Its Market Capitalisation was AUD 12.35 mn.

Probiotics Target Livestock Applications

Terragen identifies its Probiotic for Ruminants as a commercial product intended to support gastrointestinal health and productivity in beef cattle, dairy cattle, calves and sheep. The company also lists MYLO as an established probiotic technology. Both form part of its work on naturally occurring microorganisms for agricultural applications.

The range addresses production settings that differ by animal and farm system. Terragen describes laboratory work, university partnerships and replicated commercial trials as tools it uses to build evidence for product applications.

Plant Products Extend the Portfolio

Great Land Plus is Terragen’s plant biostimulant and is used across cropping, pasture and horticultural systems. The company also lists Naturalift in its portfolio. Those products sit alongside the livestock range, giving the business applications across both commercial agriculture and home gardening.

Microbial Seed Stock Underpins Manufacturing

Terragen controls its master microbial seed stock and describes internal capabilities spanning strain identification, sequencing, formulation, fermentation and manufacturing. These are sequential steps between identifying a microorganism and turning it into a product available for commercial use.